Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Γαληνός Office Χρησιμοποιήστε δωρεάν το νέο cloud πρόγραμμα διαχείρισης κάθε σύγχρονου ιατρείου
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Πρόγραμμα συνδρομητών Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Γαληνός Mobile Κατεβάστε τη δωρεάν εφαρμογή και απολαύστε τις υπηρεσίες του Galinos.gr σε κινητό ή tablet
Γνωρίζατε οτι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα
®
 Περιεχόμενα  Φάρμακα Α - Ζ  Συγχορήγηση

DAKTARIN Oral gel (2019)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

Name of the medicinal product

DAKTARIN Oral Gel.

Qualitative and quantitative composition

Each gram of Daktarin Oral Gel contains 20 mg of miconazole. Excipients with known effect: Alcohol 7.59 mg/g. For the full list of excipients, see 6.1.

Pharmaceutical form

Oral gel. White gel with orange taste.

Therapeutic indications

Oral treatment of candidosis of the oropharynx. Miconazole gel is for use in adults, children and infants 4 months and older. Consideration should be given to official guidance on the appropriate use of ...

Posology and method of administration

For oral administration. 1 measuring spoon (provided) is equivalent to 124 mg miconazole per 5 mL gel. Oropharyngeal candidosis Infants 4-24 months: 1.25 mL (¼ measuring spoon) of gel, applied four times ...

Contraindications

Known hypersensitivity to miconazole, other imidazole derivatives or to any of the excipients listed in section 6.1. In infants less than 4 months of age or in those whose swallowing reflex is not yet ...

Special warnings and precautions for use

Miconazole is systemically absorbed and is known to inhibit CYP2C9 and CYP3A4 (see Section 5.2 Pharmacokinetic Properties) which can lead to prolonged effects of warfarin. Bleeding events, some with fatal ...

Interaction with other medicinal products and other forms of interaction

When using any concomitant medication the corresponding label should be consulted for information on the route of metabolism. Miconazole can inhibit the metabolism of drugs metabolised by the CYP3A4 and ...

Pregnancy and lactation

In animals, miconazole has shown no teratogenic effects but is foetotoxic at high oral doses. The significance of this to man is unknown. However, as with other imidazoles, Daktarin Oral Gel should be ...

Effects on ability to drive and use machines

Daktarin should not affect alertness or driving ability.

Undesirable effects

The safety of Daktarin Oral Gel was evaluated in 111 patients with oral candidiasis or oral mycoses who participated in 5 clinical trials. Of these 111 patients, 88 were adults with oral candidiasis or ...

Overdose

Symptoms In the event of accidental overdose, vomiting and diarrhoea may occur. Treatment Treatment is symptomatic and supportive. A specific antidote is not available.

Pharmacodynamic properties

ATC Code: A01AB09 and A07AC01 Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. ...

Pharmacokinetic properties

Absorption Miconazole is systemically absorbed after administration as the oral gel. Administration of a 60 mg dose of miconazole as the oral gel results in peak plasma concentrations of 31 to 49 ng/mL, ...

Preclinical safety data

Preclinical data reveal no special hazard for humans based on conventional studies of local irritation, single and repeated dose toxicity, genotoxicity, and toxicity to reproduction.

List of excipients

Purified water Pregelatinised potato starch Alcohol Polysorbate 20 Sodium saccharin Cocoa flavour Orange flavour Glycerol

Incompatibilities

None known.

Shelf life

Shelf life: 3 years.

Special precautions for storage

Do not Store above 30°C.

Nature and contents of container

Aluminium tubes containing 5g*, 15g*, 30g* 40g* or 80g gel. A 5 ml plastic spoon, marked with a 2.5 ml graduation is provided. * not marketed

Special precautions for disposal and other handling

Not applicable.

Marketing authorization holder

Janssen-Cilag Limited, 50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK

Marketing authorization number(s)

PL 00242/0048

Date of first authorization / renewal of the authorization

Date of First Authorisation: 19 July 1977 Date of Renewal of Authorisation: 22 May 2008

Date of revision of the text

26 February 2019

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση: